Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Fallopian Tube Neoplasms × capivasertib × Clear all

Sponsor

Conditions

Triple Negative Breast Neoplasms 2 Recurrence 1 Neoplasms 1 Multiple Myeloma 1 Lymphoma, Mantle-Cell 1 Lymphoma, Follicular 1 Lymphoma, B-Cell, Marginal Zone 1 Lymphoma, B-Cell 1 Lymphoma 1 Locally Advanced (Inoperable) or Metastatic Breast Cancer 1 Hematologic Neoplasms 1 Carcinosarcoma 1 Carcinoma, Endometrioid 1 Breast Neoplasms 1 Advanced Solid Malignancy, 1

Interventions

Paclitaxel 57 Carboplatin 51 Bevacizumab 41 Taxes 28 liposomal doxorubicin 21 Gemcitabine 19 Immunoglobulin G 17 Disulfides 17 pembrolizumab 14 Topotecan 12 rucaparib 10 Cyclophosphamide 9 Cisplatin 9 Docetaxel 8 olaparib 7 Doxorubicin 7 pazopanib 6 mirvetuximab soravtansine 6 cediranib 6 Nivolumab 6 Magnetic Resonance Spectroscopy 6 Specimen Handling 5 sargramostim 4 niraparib 4 Surgical Procedures, Operative 4 Drug Therapy 4 Cytoreduction Surgical Procedures 4 Albumin-Bound Paclitaxel 4 veliparib 3 fludarabine phosphate 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡